Literature DB >> 12509507

Polyglutamine fibrillogenesis: the pathway unfolds.

Christopher A Ross1, Michelle A Poirier, Erich E Wanker, Mario Amzel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12509507      PMCID： PMC140861          DOI： 10.1073/pnas.0237018100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  48 in total

Review 1.  Aggresomes, inclusion bodies and protein aggregation.

Authors:  R R Kopito
Journal:  Trends Cell Biol       Date:  2000-12       Impact factor: 20.808

2.  Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.

Authors:  F C Nucifora ; M Sasaki; M F Peters; H Huang; J K Cooper; M Yamada; H Takahashi; S Tsuji; J Troncoso; V L Dawson; T M Dawson; C A Ross
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

3.  The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

Authors:  J S Steffan; A Kazantsev; O Spasic-Boskovic; M Greenwald; Y Z Zhu; H Gohler; E E Wanker; G P Bates; D E Housman; L M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  Impairment of the ubiquitin-proteasome system by protein aggregation.

Authors:  N F Bence; R M Sampat; R R Kopito
Journal:  Science       Date:  2001-05-25       Impact factor: 47.728

Review 5.  Beyond the Qs in the polyglutamine diseases.

Authors:  H T Orr
Journal:  Genes Dev       Date:  2001-04-15       Impact factor: 11.361

6.  Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.

Authors:  S Waelter; A Boeddrich; R Lurz; E Scherzinger; G Lueder; H Lehrach; E E Wanker
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

7.  Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity.

Authors:  S Chen; V Berthelier; W Yang; R Wetzel
Journal:  J Mol Biol       Date:  2001-08-03       Impact factor: 5.469

8.  CREB-binding protein sequestration by expanded polyglutamine.

Authors:  A McCampbell; J P Taylor; A A Taye; J Robitschek; M Li; J Walcott; D Merry; Y Chai; H Paulson; G Sobue; K H Fischbeck
Journal:  Hum Mol Genet       Date:  2000-09-01       Impact factor: 6.150

9.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.

Authors:  J S Steffan; L Bodai; J Pallos; M Poelman; A McCampbell; B L Apostol; A Kazantsev; E Schmidt; Y Z Zhu; M Greenwald; R Kurokawa; D E Housman; G R Jackson; J L Marsh; L M Thompson
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

10.  Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.

Authors:  C Zuccato; A Ciammola; D Rigamonti; B R Leavitt; D Goffredo; L Conti; M E MacDonald; R M Friedlander; V Silani; M R Hayden; T Timmusk; S Sipione; E Cattaneo
Journal:  Science       Date:  2001-06-14       Impact factor: 47.728
View more
  33 in total

1.  Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia.

Authors:  Cristy Tower; Lianwu Fu; Rachel Gill; Mark Prichard; Mathieu Lesort; Elizabeth Sztul
Journal:  Neurobiol Dis       Date:  2010-08-20       Impact factor: 5.996

2.  SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776.

Authors:  Lisa Duvick; Justin Barnes; Blake Ebner; Smita Agrawal; Michael Andresen; Janghoo Lim; Glenn J Giesler; Huda Y Zoghbi; Harry T Orr
Journal:  Neuron       Date:  2010-09-23       Impact factor: 17.173

3.  Disease-associated polyglutamine stretches in monomeric huntingtin adopt a compact structure.

Authors:  Clare Peters-Libeu; Jason Miller; Earl Rutenber; Yvonne Newhouse; Preethi Krishnan; Kenneth Cheung; Danny Hatters; Elizabeth Brooks; Kartika Widjaja; Tina Tran; Siddhartha Mitra; Montserrat Arrasate; Luis A Mosquera; Dean Taylor; Karl H Weisgraber; Steven Finkbeiner
Journal:  J Mol Biol       Date:  2012-01-28       Impact factor: 5.469

4.  Molecular dynamics simulations indicate a possible role of parallel beta-helices in seeded aggregation of poly-Gln.

Authors:  Martina Stork; Armin Giese; Hans A Kretzschmar; Paul Tavan
Journal:  Biophys J       Date:  2005-01-21       Impact factor: 4.033

Review 5.  Breaking symmetry in protein dimers: designs and functions.

Authors:  Jerry H Brown
Journal:  Protein Sci       Date:  2006-01       Impact factor: 6.725

Review 6.  Neurodegenerative disorders: Parkinson's disease and Huntington's disease.

Authors:  S M Hague; S Klaffke; O Bandmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

7.  Cytosolic chaperonin protects folding intermediates of Gbeta from aggregation by recognizing hydrophobic beta-strands.

Authors:  Susumu Kubota; Hiroshi Kubota; Kazuhiro Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

Review 8.  Non-coding RNAs in polyglutamine disorders: friend or foe?

Authors:  Sonali Sengupta; Subramaniam Ganesh
Journal:  J Biosci       Date:  2008-06       Impact factor: 1.826

9.  Comprehensive experimental fitness landscape and evolutionary network for small RNA.

Authors:  José I Jiménez; Ramon Xulvi-Brunet; Gregory W Campbell; Rebecca Turk-MacLeod; Irene A Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

Review 10.  A novel therapeutic strategy for polyglutamine diseases by stabilizing aggregation-prone proteins with small molecules.

Authors:  Motomasa Tanaka; Yoko Machida; Nobuyuki Nukina
Journal:  J Mol Med (Berl)       Date:  2005-03-10       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.